Product Center
The Ab&B Bio Promotion Business Conference and 10th Anniversary Celebration were successfully held
- Categories:Company news
- Author:
- Origin:
- Time of issue:2026-04-25
- Views:
(Summary description)Innovate with wisdom, embark on a new journey together. On April 23-24, 2026, Ab&B Bio-Tech Co., Ltd. JS (hereinafter referred to as "Ab&B Bio") successfully held the "Innovate with wisdom, and move forward together towards a brilliant future." Promotion Conference and the company's 10th anniversary celebration. Partners, industry experts, and company management from all over the country gathered together to visit the latest developments in the three major industrialization bases, gather consensus, and embark on the third five-year journey of struggle together!
The Ab&B Bio Promotion Business Conference and 10th Anniversary Celebration were successfully held
(Summary description)Innovate with wisdom, embark on a new journey together. On April 23-24, 2026, Ab&B Bio-Tech Co., Ltd. JS (hereinafter referred to as "Ab&B Bio") successfully held the "Innovate with wisdom, and move forward together towards a brilliant future." Promotion Conference and the company's 10th anniversary celebration. Partners, industry experts, and company management from all over the country gathered together to visit the latest developments in the three major industrialization bases, gather consensus, and embark on the third five-year journey of struggle together!
- Categories:Company news
- Author:
- Origin:
- Time of issue:2026-04-25 11:29
- Views:
Innovate with wisdom, embark on a new journey together. On April 23-24, 2026, Ab&B Bio-Tech Co., Ltd. JS (hereinafter referred to as "Ab&B Bio") successfully held the "Innovate with wisdom, and move forward together towards a brilliant future." Promotion Conference and the company's 10th anniversary celebration. Partners, industry experts, and company management from all over the country gathered together to visit the latest developments in the three major industrialization bases, gather consensus, and embark on the third five-year journey of struggle together!
On the eve of the conference, the company organized all representatives of promoters to visit the company's three major industrialization bases. At present, all three production parks have been fully formed, laying a solid production capacity foundation for the commercialization of multi variety pipelines in the future. Each park is advancing the workshop decoration and equipment installation work in a scientific and orderly manner based on the company's pipeline research and development progress. All construction production lines have achieved digital system control, covering quality assurance throughout the entire lifecycle.
In the workshops of freeze-dried human rabies vaccine (human diploid cells) and recombinant herpes zoster vaccine, cutting-edge equipment application and scientific flow line design allowed representatives to intuitively feel the company's solid foundation in industrialization. Many customers couldn't help but exclaim, "Seeing these hard power, we are full of confidence in future cooperation!”
In the workshops of freeze-dried human rabies vaccine (human diploid cells) and recombinant herpes zoster vaccine, cutting-edge equipment application and scientific flow line design allowed representatives to intuitively feel the company's solid foundation in industrialization. Many customers couldn't help but exclaim, "Seeing these hard power, we are full of confidence in future cooperation
Core goal: To become one of the top tier enterprises in Chinese human vaccines by the end of the third five years
Four major strategies: innovation driven, quality leadership, management efficiency improvement, and overseas expansion
Product Matrix: Build a vaccine product matrix driven by "prevention+tumor treatment" to accelerate breakthroughs in key technologies
Operation System: Build a three in one Ab&B Bio characteristic operation system of "AI intelligent research and development+intelligent manufacturing+precision marketing"
Operation System: Build a three in one Ab&B Bio characteristic operation system of "AI intelligent research and development+intelligent manufacturing+precision marketing"
The conference has specially invited experts from IQVIA to provide a themed training on "Breaking through Symbiosis: AI Driven Pharmaceutical Innovation and Commercialization Implementation". The expert system elaborates on the development process, core principles, application scenarios of commonly used tools, and real cases in various aspects of enterprise operation of AI. The training content provides solid theoretical support and practical path guidance for the company to build a three in one operation system of "AI intelligent research and development+intelligent manufacturing+precision marketing". The participating promoters all said, "It turns out that AI is so close to vaccine marketing, and the future really has arrived.”
Standing at the new starting point of the third five-year plan, Ab&B Bio will take "innovation driven" as the spear, "quality leadership" as the shield, "management efficiency improvement" as the foundation, and "overseas expansion" as the wing, working together with all promotional partners to continue striving towards the beautiful vision of enabling China to use global innovative vaccines and the world to use high-quality Chinese vaccines, and contributing more solid "vaccine power" to a healthy China!
Relevant information
-
Phase I/II Clinical Trial of the Re engineered Respiratory Syncytial Virus Vaccine (CHO Cells)(Adjuvant)Officially LaunchedOn May 13, the launch meeting for the Phase I/II clinical trial of the recombinant respiratory syncytial virus vaccine (CHO cell-based) (adjuvant) independently developed by Ab&B Bio-Tech CO.,LTD.JS. (Ab&B Bio) was successfully held at the research site in Sichuan. - The mRNA technology platform has achieved another milestone, with global innovation efforts accelerating. 05-08
- Our innovative vaccine research team won the 20th "Jiangsu Youth May Fourth Medal Collective" award 04-27
- The Ab&B Bio Promotion Business Conference and 10th Anniversary Celebration were successfully held 04-25
- Steadily promoting national recruitment and supplementation standards, the first and only trivalent influenza virus subunit vaccine for the entire population helps global 2026 influenza prevention and control! 04-14
Got a project? Contact us today !
At Ab&B Bio, our mission is to care for life and protect health by developing globally innovative vaccines.
Contact
E-mail:haixin.zhang@yitherbiotech.com
Add:No. 32, Xinglin Road, Medical High-tech Zone, Taizhou City
Quick view
Follow us
